Quinone prodrug compositions and methods of use
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A01N-043/42
A61K-031/47
출원번호
US-0201170
(2005-08-11)
등록번호
US-8614228
(2013-12-24)
발명자
/ 주소
Ashwell, Mark A.
Tandon, Manish
Lapierre, Jean-Marc
Liu, Yanbin
출원인 / 주소
ArQule, Inc.
대리인 / 주소
Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
인용정보
피인용 횟수 :
0인용 특허 :
19
초록▼
The present invention relates to quinone prodrug compositions and therapeutic methods using such prodrug compositions. Preferably, the quinone compounds of the invention are napthoquinone compounds such as β-lapachone or β-lapachone analogs. The quinone prodrug compositions of the invention exhibit
The present invention relates to quinone prodrug compositions and therapeutic methods using such prodrug compositions. Preferably, the quinone compounds of the invention are napthoquinone compounds such as β-lapachone or β-lapachone analogs. The quinone prodrug compositions of the invention exhibit improved solubility, stability, bioavailability, and pharmacokinetic properties, as well as improved plasma half-life in vivo.
대표청구항▼
1. A quinone prodrug composition comprising a quinone compound of formula I wherein R1 is H or C1-C4 alkyl, optionally substituted with a sulfyl (—SH or thio alkyl) group;R4 is C1-C4 alkyl, aryl or heteroaryl, wherein said aryl or heteroaryl is selected from the group consisting of phenyl, pyridyl,
1. A quinone prodrug composition comprising a quinone compound of formula I wherein R1 is H or C1-C4 alkyl, optionally substituted with a sulfyl (—SH or thio alkyl) group;R4 is C1-C4 alkyl, aryl or heteroaryl, wherein said aryl or heteroaryl is selected from the group consisting of phenyl, pyridyl, imidazole and thiazole, and is optionally substituted with one or more independently selected C1-C3 alkyl groups;the pro-moiety is selected from —(C1-C11)alkyl, —(C0-C6)alkyl-aryl, —(C0-C6)alkyl-heteroaryl, —(C0-C6)alkyl-aryl-heteroaryl, —(C0-C6)alkyl-COOH, —(C1-C6)alkyl-OH, 1-pyridyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, aryl-heteroaryl, and n is 0, 1, 2 or 3, with the proviso that when n is 0, R1 is not present. 2. The quinone prodrug composition of claim 1, wherein the quinone compound is β-lapachone. 3. A quinone prodrug composition, wherein the composition is a compound selected from the group consisting of 4. A pharmaceutical composition comprising a therapeutically effective amount of at least one quinone prodrug composition and a pharmaceutically acceptable excipient, wherein said quinone prodrug composition comprises a quinone compound of formula I wherein R1 is H or C1-C4 alkyl, optionally substituted with a sulfyl (—SH or thio alkyl) group;R4 is C1-C4 alkyl, aryl or heteroaryl, wherein said aryl or heteroaryl is selected from the group consisting of phenyl, pyridyl, imidazole and thiazole, and is optionally substituted with one or more independently selected C1-C3 alkyl groups;the pro-moiety is selected from —(C1-C11)alkyl, —(C0-C6)alkyl-aryl, —(C0-C6)alkyl-heteroaryl, —(C0-C6)alkyl-aryl-heteroaryl, —(C0-C6)alkyl-COOH, —(C1-C6)alkyl-OH, 1-pyridyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, aryl-heteroaryl, and n is 0, 1, 2 or 3, with the proviso that when n is 0, R1 is not present. 5. The pharmaceutical composition of claim 4, wherein the pharmaceutical composition is an aqueous solution. 6. The pharmaceutical composition of claim 4, wherein the pharmaceutical composition is a lyophilized solid. 7. The pharmaceutical composition of claim 4, wherein the pharmaceutical composition comprises 0.1 mg/ml to 10 mg/ml of the quinone prodrug composition. 8. The pharmaceutical composition of claim 4, further comprising a second anticancer agent. 9. The pharmaceutical composition of claim 8, wherein the second anticancer agent is selected from the group consisting of taxane derivatives, gemcitabine, cisplatin, imatnibmeasylate, and trastuzumab. 10. The pharmaceutical composition of claim 9, wherein the taxane derivative is paclitaxel or docetaxol. 11. A kit for the treatment of a mammalian cancer comprising at least one vial containing a quinone prodrug composition of claim 1. 12. A kit of claim 11, wherein the kit further comprises, within in the same vial or a separate vial, a second anticancer agent. 13. The kit of claim 12, wherein the second anticancer agent is selected from the group consisting of taxane derivatives, gemcitabine, cisplatin, imatnibmeasylate, and trastuzumab. 14. The kit of claim 13, wherein the taxane derivative is paclitaxel or docetaxol. 15. The quinone prodrug composition of claim 1, wherein R4 is methyl. 16. The quinone prodrug composition of claim 1, wherein said aryl is phenyl. 17. The quinone prodrug composition of claim 1, wherein said aryl is substituted with C1-C6 alkyl. 18. The quinone prodrug composition of claim 1, wherein said heteroaryl is selected from the group consisting of pyridyl, imidazole and thiazole. 19. The quinone prodrug composition of claim 1, wherein said heteroaryl is substituted with C1-C6 alkyl. 20. The quinone prodrug composition of claim 1, wherein said pro-moiety is selected from —COOH, —CH2—COOH and —(CH2)2—COOH.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (19)
Gutteridge Winston Edward,GB2 ; Hudson Alan Thomas,GB2 ; Latter Victoria Susan,GB2 ; Pudney Mary,GB2, Antiprotozoal medicaments.
Boyd Michael R. ; Cardellina ; II John H. ; Gustafson Kirk R. ; Decosterd Laurent A.,CHX ; Parson Ian ; Pannell Lewis ; McMahon James B. ; Cragg Gordon M., Antiretroviral naphthoquinone compounds compositions and uses thereof.
Frydman Benjamin J. ; Witiak Donald T. ; Sun Jerry Shunneng ; Geiser Andrew H., Ortho-quinone derivatives novel synthesis therefor and their use in the inhibition of neoplastic cell growth.
Frydman Benjamin J. ; Witiak ; deceased Donald T. ; Sun Jerry Shunneng ; Geiser Andrew H., Ortho-quinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth.
Jiang, Zhiwei; Reddy, Dasharatha G., Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same.
Jiang,Zhiwei; Reddy,Dasharatha G., Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same.
McCall John M. (Kalamazoo MI) Ayer Donald E. (Kalamazoo MI) Jacobsen E. Jon (Plainwell MI) VanDoornik Frederick J. (Hamilton MI) Palmer John R. (Kalamazoo MI), Pharmaceutically active amines.
Ubillas Rosa P. (Foster City CA) Shivanand Jolad D. (San Carlos CA) Mendez Christopher D. (San Francisco CA) Fort Diana M. (Pacifica CA) Evans Joseph L. (San Francisco CA) Luo Jian (Brisbane CA), Terpenoid-type quinones for treatment of diabetes.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.